New Delhi [India], December 28 (ANI): Union Minister of Health and Family Welfare Mansukh Mandaviya on Tuesday announced the approval of two new indigenously developed vaccines and one anti-viral drug for the treatment of the adult patients of COVID-19 having a "high risk of progression o
New Delhi [India], December 28 (ANI): After reviewing all applications and data, the Subject Expert Committee (SEC), a body under India's drug regulator, has recommended granting the Emergency Use Authorization (EUA) to Serum Institute of India's COVID-19 vaccine Covovax and Corbevax vacc
New Delhi [India], December 17 (ANI): After the Covovax vaccine got WHO's approval for emergency use, Chief Executive Officer of the Serum Institute of India Adar Poonawalla on Friday said that this is yet another milestone in our fight against COVID-19.
Geneva [Switzerland], December 17 (ANI): The World Health Organization (WHO) said it had approved the Covovax coronavirus vaccine, which is manufactured by the Serum Institute of India under license from US company Novavax, for emergency use.
Pune (Maharashtra) [India], October 1 (ANI): Phase 2/3 trials of Covovax COVID-19 vaccine in children between ages 7 and 11 began in Pune's Bharati Vidyapeeth Medical College and Hospital on Wednesday.
New Delhi [India], March 27 (ANI): Pune-based Serum Institute of India CEO Adar Poonawalla on Saturday informed that the trials for 'Covovax', a vaccine developed by Novavax, have begun in India, and added that he is hoping the vaccine launch will take place by September this year.
New Delhi [India], January 30 (ANI): Pharma giant Serum Institute of India (SII), whose Covishield vaccine has already received restricted emergency use approval by the Drugs Controller General of India (DCGI), has now sought permission to start clinical trials of 'COVOVAX', a COVID-19 vacci